Figure 1. Interleukin (IL)-22 levels in the serum from type 2 diabetes mellitus (T2DM) patients (n=29) and healthy control subjects (n=30) were measured by FlowCytomix. Student's t-test showed that concentrations of IL-22 in serum were significantly lower in patients with T2DM than in healthy control subjects (p=0.007).